CENP-V Inhibitors

Microtubule-targeting agents such as Paclitaxel, Nocodazole, Colchicine, Taxol, Vinblastine, Mebendazole, Griseofulvin, and Podophyllotoxin can alter the stability and assembly of microtubules. This is significant because the proper function of CENP-V is closely tied to the integrity of the mitotic spindle and the physical process of chromosomal segregation. By stabilizing or destabilizing microtubules, these compounds can prevent the correct attachment of chromosomes to the spindle, which in turn can impair the function of CENP-V in ensuring accurate chromosome alignment and movement. In addition to agents that directly modulate microtubules, inhibitors targeting key kinases involved in cell cycle regulation also form part of the CENP-V Inhibitors. Compounds such as Monastrol and the Plk1 and Aurora A kinase inhibitors work by disrupting the activity of proteins that are responsible for proper spindle formation, function, and checkpoint control during mitosis.

Microtubule-stabilizing agents like Paclitaxel and Taxol promote microtubule polymerization and can hinder the dynamic changes required for microtubules to capture and segregate chromosomes correctly, which may affect the role of CENP-V in mitosis. Conversely, microtubule-destabilizing compounds such as Nocodazole, Colchicine, Vinblastine, Mebendazole, Griseofulvin, and Podophyllotoxin disrupt microtubule polymerization and spindle formation. The disruption of these structures can impair CENP-V's ability to mediate chromosomal movements and alignment on the spindle apparatus. Furthermore, compounds like Monastrol, which inhibits the kinesin motor protein Eg5, result in the formation of monopolar spindles, again influencing the environment in which CENP-V operates. Similarly, inhibitors targeting essential mitotic kinases such as Plk1 and Aurora A can lead to defects in spindle assembly and checkpoint function. The Plk1 inhibitor impedes spindle pole assembly, while the Aurora A inhibitor disrupts centrosome maturation. Both kinases are pivotal for the centromeric functions that CENP-V is presumed to partake in during cell division. By deranging the orderly progression of mitosis through these kinase inhibitors, the precise role of CENP-V in ensuring proper chromosome segregation is likely to be compromised.